GlaxoSmithKline PLCGSK:LSE

1,559
4.50 / 0.29 %
9.79m
2.99 %
0.4756
Close in GBXToday's changeShares traded1 year changeBeta
As of Apr 17 2014 17:10 BST.Data delayed by at least 15 minutes.

Summary

On Thursday, GlaxoSmithKline PLC (GSK:LSE) closed at 1,559, 2.03% above its 52-week low of 1,528, set on Apr 14, 2014.

52-week range
Today
1,528
Apr 14 2014
1,816
May 28 2013
Open1,557
Day high1,560
Day low1,545
Bid1,549
Offer1,585
Previous close1,563.5
Average volume9.39m
Shares outstanding4.86bn
Free float4.79bn
P/E (TTM)14.03
Market cap75.78bn GBP
EPS (TTM)1.11 GBP
Annual div (TTM)78.00 GBX
Annual div yield (TTM)5.00%
Div ex-dateFeb 19 2014
Div pay-dateApr 10 2014
Last IC View
The last IC recommendation on GlaxoSmithKline PLC shares was Buy at 1,570 on 06 Feb 2014
Read the full article

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
GlaxoSmithKline PLC-1.42 %-4.79 %-0.95 %-2.99 %+50.19 %
FTSE 100 Index-0.25 %+0.87 %+0.75 %+6.10 %+61.88 %
GB/HEALTH CARE+0.33 %-6.12 %+6.60 %+5.06 %--
GB/PHARMACEUTICALS+0.46 %-6.02 %+6.46 %+4.40 %--
As of Apr 17 2014 17:10 BST.Data delayed by at least 15 minutes.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.